1. Home
  2. VIAV vs FOLD Comparison

VIAV vs FOLD Comparison

Compare VIAV & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

HOLD

Current Price

$20.42

Market Cap

4.1B

Sector

Technology

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.29

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIAV
FOLD
Founded
1923
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.4B
IPO Year
1993
2007

Fundamental Metrics

Financial Performance
Metric
VIAV
FOLD
Price
$20.42
$14.29
Analyst Decision
Strong Buy
Buy
Analyst Count
8
10
Target Price
$18.04
$26.11
AVG Volume (30 Days)
3.3M
10.2M
Earning Date
01-28-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$1,145,200,000.00
$598,704,000.00
Revenue This Year
$30.31
$21.49
Revenue Next Year
$8.70
$18.46
P/E Ratio
$326.48
N/A
Revenue Growth
15.60
21.28
52 Week Low
$8.10
$5.51
52 Week High
$20.27
$14.38

Technical Indicators

Market Signals
Indicator
VIAV
FOLD
Relative Strength Index (RSI) 67.37 81.20
Support Level $18.57 $14.30
Resistance Level $19.90 $14.36
Average True Range (ATR) 0.85 0.05
MACD 0.18 -0.17
Stochastic Oscillator 97.77 20.83

Price Performance

Historical Comparison
VIAV
FOLD

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: